The pilot study showed that the median UCHL1 in cerebrospinal fluid in the control group (n = 31) was 4.5 μg/L, while in the AD group (n = 10) it was significantly higher: 12 μg/L. The gene discussed is UCHL1; the disease is Alzheimer disease.